Jonathan David Schwartz, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 24,379 shares at $10.58 ($357K) on 2025-02-25, disclosed to the SEC on 2025-02-27.
Open-market sale of $357k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.35 | 2,754 | $64K | 18.0% |
| 2 | $23.35 | 2,754 | $64K | 18.0% |
| 3 | $18.50 | 2,710 | $50K | 14.0% |
| 4 | $13.05 | 3,097 | $40K | 11.3% |
| 5 | $10.58 | 6,532 | $69K | 19.3% |
| 6 | $10.58 | 6,532 |
| $69K |
| 19.3% |
| Total | $14.66 avg | 24,379 | $357K | 100% |
| Filing → |
| RCKT | SELL | 2025-08-18 | $34K | — | Filing → |
| RCKT | SELL | 2025-05-22 | $5K | — | Filing → |
| RCKT | SELL | 2025-05-20 | $10K | — | Filing → |